FDA Brief

Warning letters Drugs

FDA warning letter to

CoLabs Intl. Corp

MediumIssued Mar 12, 2025Posted Mar 18, 2025Center for Drug Evaluation and Research (CDER)

CoLabs Intl. Corp marketed KLĒNSKIN WASH ON SUNSCREEN, an OTC sunscreen wash, without an FDA-approved application or authorized dosage form.

What happened

In May 2024, FDA reviewed the product labeling, including the website https://www.klenskin.com/, and found KLĒNSKIN WASH ON SUNSCREEN available for purchase without a prescription. The labeling claims broad-spectrum SPF 30 protection and everyday sunscreen use, so FDA treated it as an OTC sunscreen drug product. FDA found no approved application and no final order authorizing a shampoo or face/body wash sunscreen dosage form.

What FDA found

  1. The product is a drug because its labeling says it prevents sun damage and affects the body.

    FD&C Act section 201(g)(1)(B)/(C), 21 U.S.C. 321(g)(1)(B)/(C)
  2. The product is misbranded because it is a nonprescription drug subject to section 505G but does not meet that section’s marketing requirements and has no approved application.

    FD&C Act sections 502(ee) and 301(a), 21 U.S.C. 352(ee) and 331(a)
  3. A sunscreen in wash or shampoo dosage form is not one of the dosage forms allowed under the OTC sunscreen order, and no FDA order authorizes it.

    FD&C Act section 505G(m)(2), 21 U.S.C. 355h(m)(2)
  4. No FDA-approved application under section 505 is in effect for the product.

    FD&C Act section 505, 21 U.S.C. 355

What FDA wants

FDA asks the company to notify it in writing within 15 working days of receipt of the specific steps taken to correct the violations, including explanations and related documentation; if correction cannot be completed in that time, the company must state why and when it will be completed.

Who should pay attention

  • OTC sunscreen brands
  • companies making or selling wash-off sunscreen dosage forms
  • retailers and online marketplaces listing KLĒNSKIN products

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. New Green Nutrition Inc.

    FDA says New Green Nutrition sold unapproved drugs online, and its Qu Feng Huo Luo Dan contained hidden dexamethasone.

    High risk
  2. Ong Tien USA LLC

    FDA warned Ong Tien USA LLC that its herbal joint products are unapproved drugs and one contained hidden piroxicam and dexamethasone.

    High risk
  3. Bella’s Nutri Shop Inc.

    Bella’s Nutri Shop sells “Tawon Liar” as an unapproved drug with hidden dexamethasone, tapentadol, and meloxicam.

    High risk
  4. Phuoc Loc Tho Herbals, Inc.

    FDA warned Phuoc Loc Tho Herbals that its herbal products are unapproved new drugs marketed with disease claims.

    High risk